MINNEAPOLIS (AP) — MINNEAPOLIS (AP) — Techne Corp. (TECH) on Wednesday reported fiscal first-quarter earnings of $33.6 million. The Minneapolis-based company said it had net income of 21 cents ...

Techne (TECH) came out with quarterly earnings of $0.42 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.41 per share a year ago. These figures ...

Mirae Asset Global Investments Co. Ltd. increased its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 38.4% in the third quarter, according to its most recent filing with the ...

A month has gone by since the last earnings report for Techne (TECH). Shares have added about 2.2% in that time frame, underperforming the S&P 500. Will the recent positive trend continue leading up ...

Bio-Techne Trading Up 0.8 % Bio-Techne stock opened at $76.42 on Friday. Bio-Techne Co. has a 52 week low of $55.63 and a 52 week high of $85.57. The company has a debt-to-equity ratio of 0.14, a ...

Minneapolis, Minnesota-based Bio-Techne Corporation (TECH) develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets.

Bio-Techne Corporation (NASDAQ: TECH) today announced its lineup of presentations and activities for the Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo, taking place November ...

(RTTNews) - Life sciences company Bio-Techne Corp. (TECH) announced Wednesday a partnership with Leader Life Sciences under which Leader Life Sciences will become a distributor of Bio-Techne's ...

Under the agreement, GeminiBio gets the manufacturing and global sales rights for Bio-Techne's Fetal Bovine Serum (FBS) products such as Optima, Premium Select, and Premium. Chief Executive ...

Customers will present data from their use of novel assays and kits; company will host educational workshops and discussions for attendees "The Association for Molecular Pathology is a leading ...